The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Mastopexy Global Market Report 2024, the mastopexy market is expected to show significant growth in the forecast period.

The mastopexy market has experienced strong growth in recent years, driven by several key factors. In 2023, the market reached $2.22 billion and is expected to grow to $2.36 billion by 2024, reflecting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth include:

• Increasing social acceptance of cosmetic procedures
• Rising number of bariatric surgeries
• Adoption of virtual consultations and telemedicine
• Establishment of specialized cosmetic surgery centers
• Shift towards patient-centered care models in cosmetic surgery

Forecasted Market Expansion

The market is expected to continue its upward trajectory, reaching $3.02 billion by 2028 with a CAGR of 6.3%. Key drivers of this growth include:

• Enhanced pre-operative counseling and post-operative care
• Increased focus on overall health and self-care
• Advancements in anesthesia techniques
• Growing aging population
• Rising disposable incomes

Significant trends shaping this forecast period include advancements in implant technology, scar management techniques, surgical education, and regenerative medicine.

View More On The Mastopexy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/mastopexy-global-market-report

Key Market Driver: Rising Female Geriatric Population

One of the most significant drivers of the mastopexy market is the increasing female geriatric population. As life expectancy rises and healthcare improves, more women over the age of 65 are considering breast lift surgery to address age-related changes in breast contour. For example, in the U.S., the percentage of women aged 65 and older grew from 18.1% in 2021 to 19.1% in 2023, further boosting the demand for mastopexy procedures.

Market Leaders and Innovations

Several major companies are leading the mastopexy market, including AbbVie Inc., Hologic Inc., Spire Healthcare Group, and Cynosure Inc. These companies are continually innovating to stay competitive, particularly in the area of nipple reconstruction. A notable development is GC Aesthetics’ introduction of the FixNip NRI in 2024, a biocompatible nipple implant designed to improve breast reconstruction outcomes with minimal incisions.

Mergers and Acquisitions Driving Innovation

Mergers and acquisitions are playing a key role in the advancement of surgical technologies. For instance, in July 2021, Becton, Dickinson, and Company (BD) acquired Tepha Inc., a company specializing in implants for mastopexy. This acquisition positions BD as a leader in surgical mesh innovations and expands its ability to offer advanced solutions for physicians and patients.

Market Segmentation and Regional Outlook

The mastopexy market is segmented by procedure type, including Benelli Lift, Crescent Breast Lift, Lollipop Lift, and Anchor Breast Lift, and by tissue incision type (skin, adipose, and glandular). End-use segments include hospitals and specialty clinics. North America was the largest regional market in 2023, while the Asia-Pacific region is expected to experience the fastest growth in the coming years.

Request A Sample Of The Global Mastopexy Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=18405&type=smp